KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 125 filers reported holding KEROS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,335,221 | +129.0% | 58,119 | +143.4% | 0.05% | +80.0% |
| Q1 2023 | $1,019,676 | -9.6% | 23,880 | +1.7% | 0.03% | -6.2% |
| Q4 2022 | $1,127,990 | +27.6% | 23,490 | -0.1% | 0.03% | +23.1% |
| Q3 2022 | $884,000 | -32.2% | 23,506 | -50.2% | 0.03% | -29.7% |
| Q2 2022 | $1,304,000 | -48.3% | 47,182 | +1.8% | 0.04% | -38.3% |
| Q1 2022 | $2,520,000 | -7.8% | 46,338 | -0.8% | 0.06% | +3.4% |
| Q4 2021 | $2,733,000 | +57.8% | 46,705 | +6.7% | 0.06% | +48.7% |
| Q3 2021 | $1,732,000 | -8.3% | 43,787 | -1.5% | 0.04% | -4.9% |
| Q2 2021 | $1,888,000 | -54.9% | 44,466 | -34.6% | 0.04% | -51.2% |
| Q1 2021 | $4,184,000 | – | 67,980 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 407,633 | $12,995,340 | 5.15% |
| Opaleye Management Inc. | 360,400 | $11,489,552 | 3.74% |
| Parkman Healthcare Partners LLC | 298,475 | $9,515,383 | 1.74% |
| BRAIDWELL LP | 1,357,309 | $43,271,011 | 1.37% |
| First Light Asset Management, LLC | 421,438 | $13,435,443 | 1.28% |
| Orbimed Advisors | 1,514,734 | $48,289,720 | 1.03% |
| Yiheng Capital Management, L.P. | 554,151 | $17,666,334 | 0.90% |
| Nantahala Capital Management | 328,781 | $10,481,538 | 0.90% |
| DAFNA Capital Management LLC | 65,961 | $2,102,837 | 0.65% |
| EDBI Pte Ltd | 10,105 | $322,147 | 0.35% |